Shirley D’Sa

5.2k citations

122 papers · 2.4k indexed · h-index 25

Impact in

Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Blood groups and transfusion
Genetics top 1%
- Chronic Lymphocytic Leukemia Research

Papers in

Hematology 65
- Multiple Myeloma Research and Treatments 30
- Blood groups and transfusion 29
Genetics 60
- Chronic Lymphocytic Leukemia Research 50

Co-authors: Kwee Yong Michael P. Lunn Guy Pratt Eric Low Roger G. Owen Jennifer M. Bird Bernd Jilma John A. Snowden
Journals: Blood (30 papers)British Journal of Haematology (24 papers)HemaSphere (7 papers)Blood Advances (5 papers)Haematologica (4 papers)
Partner nations: United Kingdom United States Netherlands

In The Last Decade

Shirley D’Sa

111 papers receiving 2.4k citations

Peers

Countries citing papers authored by Shirley D’Sa

Since Specialization

Citations

This map shows the geographic impact of Shirley D’Sa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shirley D’Sa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shirley D’Sa more than expected).

Fields of papers citing papers by Shirley D’Sa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shirley D’Sa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shirley D’Sa. The network helps show where Shirley D’Sa may publish in the future.

Co-authors

The 25 scholars most cited alongside Shirley D’Sa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shirley D’Sa Line = papers co-authored together Shirley D’Sa links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Patient Perception of the Relevance of Quality-of-Life Questionnaires in Waldenström Macroglobulinaemia: An International Survey Cancers ·Jahanzaib Khwaja, Sotirios Bristogiannis, Ibrahim Tohidi‐Esfahani, Yadanar Lwin, Nicole Japzon, David Young, Sosana Delimpasi, Shirley D’Sa, Judith Trotman, Charalampia Kyriakou	2025	0
2	Zanubrutinib in Bing Neel syndrome: efficacy and tolerability Leukemia ·Anne‐Marie L. Becking, Johannes P. M. van de Mortel, Oliver Tomkins, T.W.H. Flinsenberg, Nicole Japzon, Marie José Kersten, Jahanzaib Khwaja, Saskia Kuipers, Henriëtte Levenga, Sean McKeague, Stephen Opat, Ross Salvaris, Sherif Seif, Sheeba K. Thomas, Alexander F. J. E. Vrancken, Shirley D’Sa, Monique C. Minnema, Josephine M. I. Vos	2025	4
3	A scoping review: POEMS syndrome (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal plasma cell disorder and Skin Changes), physical recovery, and rehabilitation Clinical Rehabilitation ·Leslie Johnson, Shirley D’Sa, Gita Ramdharry, Jackie Walumbe, Michael P. Lunn, Oliver Tomkins, Jonathan Sive, Orla McCourt	2025	0
4	PembroWM : A phase II trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's Macroglobulinaemia British Journal of Haematology ·Jaimal Kothari, Toby A. Eyre, Ali Rismani, Kushani Ediriwickrema, Darren Edwards, Sevasti Galani, William Wilson, Anthony Lawrie, Laura Clifton‐Hadley, Helen O. McCarthy, Angela Collins, David Lewis, Suzanne Arulogan, Rebecca Auer, Guy Pratt, Ruth de Tute, Roger G. Owen, Shirley D’Sa	2024	3
5	Bing-Neel Syndrome - a Case Series of 46 Patients from the United Kingdom Blood ·Oliver Tomkins, Jahanzaib Khwaja, Nicole Japzon, Shiwen Koay, Chandrashekar Hoskote, Charalampia Kyriakou, Jindriska Lindsay, Michael P. Lunn, Shirley D’Sa	2024	1
6	Review of BCL2 inhibitors for the treatment of Waldenström’s macroglobulinaemia and non-IgM lymphoplasmacytic lymphoma Frontiers in Oncology ·Oliver Tomkins, Shirley D’Sa	2024	1
7	Long-term Clinical Outcomes in Patients with Waldenström Macroglobulinemia (WM) Who Received Zanubrutinib in the Phase 3 ASPEN Study: A Report from the Zanubrutinib Extension Study Blood ·Shirley D’Sa, Meletios A. Dimopoulos, Wojciech Jurczak, Paula Marlton, Stephen P. Mulligan, Björn E. Wahlin, Magdalena Sobieraj‐Teague, Andrew W. Roberts, Constantine S. Tam, Jorge J. Castillo, Heather Allewelt, Radha Prathikanti, Wai Yee Chan, Tian Tian, Jingjing Schneider, Remus Vezan, Stephen Opat	2024	1
8	Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia Leukemia ·Ruth de Tute, Nicholas Counsell, Laura Clifton‐Hadley, Shirley D’Sa, Guy Pratt, Gavin Campbell, Lauren Campbell, Ross Sadler, William Townsend, Bilyana Popova, Paul Smith, Oliver Schofield, Roger G. Owen, Rebecca Auer	2024	0
9	Long-term sutimlimab improves quality of life for patients with cold agglutinin disease: CARDINAL 2-year follow-up Blood Advances ·Alexander Röth, Catherine M. Broome, Wilma Barcellini, Tor Henrik Anderson Tvedt, Yoshitaka Miyakawa, Shirley D’Sa, David Cella, Sylvie Bozzi, Deepthi Jayawardene, Ronnie Yoo, Frank Shafer, Marek Wardęcki, Ilene C. Weitz	2023	8
10	Clinical and clonal characteristics of monoclonal immunoglobulin M‐associated type I cryoglobulinaemia British Journal of Haematology ·Jahanzaib Khwaja, Josephine M. I. Vos, Tessa E. Pluimers, Nicole Japzon, Aisha S Patel, Simon Salter, Arjan J. Kwakernaak, Rajeev Gupta, Ali Rismani, Charalampia Kyriakou, Ashutosh Wechalekar, Shirley D’Sa	2023	9
11	Classical Complement Inhibition By SAR445088 (BIVV020) in Adults with Cold Agglutinin Disease: Safety, Tolerability and Activity Results from the Open-Label, Non-Randomized, Single-Dose Phase 1b Study Blood ·Shirley D’Sa, Josephine M. I. Vos, Wilma Barcellini, Marek Wardęcki, Laurent Perrin, Graham Barker, Moshe Zilberstein, Michael Storek, Timothy Y. Chow, Alexander Roeth	2023	1
12	IgM-Associated Cryoglobulinaemia SHILAP Revista de lepidopterología ·Jahanzaib Khwaja, Simon J. Salter, Shirley D’Sa	2023	0
13	Polyneuropathy Associated with IgM Monoclonal Gammopathy; Advances in Genetics and Treatment, Focusing on Anti-MAG Antibodies SHILAP Revista de lepidopterología ·Johannes P. M. van de Mortel, Shirley D’Sa, Alexander F. J. E. Vrancken, Nicolette C. Notermans, Josephine M. I. Vos, Monique C. Minnema	2022	4
14	Peripheral nerve neurolymphomatosis: Clinical features, treatment, and outcomes Muscle & Nerve ·Stephen Keddie, Arjuna Nagendran, T.G. Hunter Cox, Joshua Bomsztyk, Zane Jaunmuktane, Sebastian Brandner, Hadi Manji, Jeremy Rees, Alan D. Ramsay, Alexander M. Rossor, Shirley D’Sa, Mary M. Reilly, Aisling Carr, Michael P. Lunn	2020	16
15	PF487 MAJOR RESPONSES IN MYD88 WILDTYPE (MYD88WT) WALDENSTRÖM MACROGLOBULINEMIA (WM) PATIENTS TREATED WITH BRUTON TYROSINE KINASE (BTK) INHIBITOR ZANUBRUTINIB (BGB‐3111) HemaSphere ·Meletios Α. Dimopoulos, Stephen Opat, Hagyeong Lee, Gavin Cull, Shirley D’Sa, Roger G. Owen, Alessandra Tedeschi, (unknown), Marzia Varettoni, Christian Buske, V. Leblond, Wai‐Yee Chan, J Schneider, Mohammed A. Osman, Aileen Cohen, Jennifer J. Huang, Constantine S. Tam	2019	7
16	Frequent central nervous system, pachymeningeal and plexus MRI changes in POEMS syndrome Journal of Neurology ·Oliver J. Ziff, Chandrashekar Hoskote, Stephen Keddie, Shirley D’Sa, Indran Davangnanam, Michael P. Lunn	2019	19
17	Investigation and management of IgM and Waldenström‐associated peripheral neuropathies: recommendations from the IWWM ‐8 consensus panel British Journal of Haematology ·Shirley D’Sa, Marie José Kersten, Jorge J. Castillo, Meletios Α. Dimopoulos, Efstathios Kastritis, Edward Laane, Véronique Leblond, Giampaolo Merlini, Steven P. Treon, Josephine M. I. Vos, Michael P. Lunn	2017	47
18	Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease response British Journal of Haematology ·Arash Latifoltojar, Margaret Hall‐Craggs, Neil Rabin, Rakesh Popat, Alan Bainbridge, Νικόλαος Δικαίος, Magdalena Sokolska, Ali Rismani, Shirley D’Sa, Shonit Punwani, Kwee Yong	2016	46
19	Assessing the Relation Between Bone Marrow Signal Intensity and Apparent Diffusion Coefficient in Diffusion-Weighted MRI American Journal of Roentgenology ·Anwar R. Padhani, Katherine van Ree, David J. Collins, Shirley D’Sa, Andreas Makris	2012	107
20	Guidelines for supportive care in multiple myeloma 2011 British Journal of Haematology ·John A. Snowden, Sam H. Ahmedzai, John Ashcroft, Shirley D’Sa, Timothy J. Littlewood, Eric Low, H.H. Lucraft, Rhona Maclean, Sylvia Feyler, Guy Pratt, Jennifer M. Bird	2011	153

About Shirley D’Sa

Shirley D’Sa is a scholar working on Hematology, Genetics, Neurology, Pathology and Forensic Medicine and Immunology, having authored 122 papers that have together received 2.4k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (50 papers), Multiple Myeloma Research and Treatments (30 papers), Blood groups and transfusion (29 papers), Lymphoma Diagnosis and Treatment (24 papers), Peripheral Neuropathies and Disorders (20 papers), Erythrocyte Function and Pathophysiology (17 papers), Immunodeficiency and Autoimmune Disorders (15 papers) and Cancer Treatment and Pharmacology (10 papers). The work is most often cited by research in Hematology (1.4k citations), Genetics (758 citations), Pathology and Forensic Medicine (569 citations), Neurology (363 citations) and Oncology (628 citations). Shirley D’Sa has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Kwee Yong, Michael P. Lunn, Guy Pratt, Eric Low, Roger G. Owen, Jennifer M. Bird, Bernd Jilma, John A. Snowden, Sylvia Feyler and John Ashcroft. Their work appears in journals such as Blood, British Journal of Haematology, HemaSphere, Blood Advances and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact